notificationsアラート設定
~
検索条件をクリア

アブストラクト

Japanese

Title 中枢神経障害によるしびれ感に対するしびれ同調経皮的電気神経刺激の効果検証 : シングルケース実験デザイン
Subtitle II. 原著
Authors 西祐樹1,2), 生野公貴3), 南川勇二3), 中田佳佑3), 大住倫弘2), 森岡周2)
Authors (kana)
Organization 1)長崎大学 生命医科学域(保健学系), 2)畿央大学 ニューロリハビリテーション研究センター, 3)西大和リハビリテーション病院
Journal 物理療法科学
Volume 30
Number
Page 67-75
Year/Month 2023 /
Article 原著
Publisher 日本物理療法学会
Abstract 「要旨」本研究では, しびれ感を呈する中枢神経系疾患におけるしびれ同調経皮的電気神経刺激(TENS)の効果を検証した. しびれ感を呈する脳卒中患者2名, 脊髄損傷患者2名, 多発性硬化症患者1名の5名における上肢計8部位を対象とした. 介入手続きは, マルチプルベースラインデザインを採用し, ベースライン期, 介入期, フォローアップ期を28日間の間で設定した. 介入期は7日間とし, しびれ感に同調したTENSを1日1時間で実施した. 各期において, しびれ感の強度をNRSにて毎日聴取した. 症例間効果をケース間標準化平均値差, 症例内効果をTau-Uにて算出した. その結果, 症例間効果では, しびれ感はしびれ同調TENS介入期に有意に改善し, その効果量も高いことが示された. また, フォローアップ期においても, その効果は持続していた. 一方, 症例内効果は全症例において介入期で高い効果量を認めたが, 脊髄損傷患者1名の両手指は同一疾患の他症例と類似した重症度にもかかわらず, フォローアップ期で有意な改善を認めなかった. 中枢神経障害によるしびれ感に対するしびれ同調TENSの一定の有効性を示唆されたが, 介入効果に関わる要因について詳細な調査が必要である.
Practice 医療技術
Keywords 経皮的電気神経刺激, しびれ感, 脳卒中, 脊髄損傷, 多発性硬化症

English

Title Dysesthesia-matched transcutaneous electrical nerve stimulation cancels out the dysesthesias by central nervous disorders : Single-case experimental design
Subtitle
Authors Yuki NISHI1,2, Koki IKUNO3, Yuji MINAMIKAWA3, Keisuke NAKATA3, Michihiro OSUMI2, Shu MORIOKA2
Authors (kana)
Organization 1Institute of Biomedical Sciences (Health Sciences), Nagasaki University, 2Neurorehabilitation Research Center, Kio University, 3Department of Rehabilitation Medicine, Nishiyamato Rehabilitation Hospital
Journal Japanese Journal of Electrophysical Agents
Volume 30
Number
Page 67-75
Year/Month 2023 /
Article Original article
Publisher Japanese Society for Electrophysical Agents in Physical Therapy
Abstract [ABSTRACT] Our previous study revealed that the dysesthesia-matched TENS (DM-TENS) effects for dysesthesias in patients with central nervous system dysfunctions. A total of 8 upper extremity sites with dysesthesias in 5 patients (2 stroke patients, 2 spinal cord injury patients, and 1 multiple sclerosis patient) were included in the study. Multiple-baseline design set with a baseline phase, intervention phase, and follow-up phase of total 28 days. In the intervention phase for 7 days, DM-TENS was applied to upper extremity sites with dysesthesias at 1 hour per day. Patients answered the numerical rating scale for the intensities of subjective dysesthesias every day. The Between-case standardized mean difference (BC-SMD) for the between-case effects and Tau-U for the within-case effects were calculated. In the results of BC-SMD, the dysesthesias were significantly improved by DM-TENS in the intervention and follow-up phases. Moreover, within-case effects were high in all patients during the intervention phase. However, both hands of one spinal cord injury patient did not show significant improvement during the follow-up phase, despite the similar severities of the spinal cord injury and dysesthesias to another patient. Our results suggest the effectiveness of DM-TENS for the dysesthesias caused by central neuropathies. Additional investigation of the factors involved in the intervention effect is needed.
Practice Medical technology
Keywords
  • 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
download全文ダウンロード(2.69MB)

参考文献

  • 1) Finnerup NB, Johannesen IL, Sindrup SH, et al. Pain and dysesthesia in patients with spinal cord injury: A postal survey. Spinal Cord. 2001; 39(5): 256-262. doi: 10. 1038/sj. sc. 3101161
  • 2) Akimoto T, Ogawa K, Morita A, et al. Clinical study of 27 patients with medial medullary infarction. J Stroke Cerebrovasc Dis. 2017; 26(10): 2223-2231. doi: 10. 1016/j. jstrokecerebrovasdis. 2017. 05. 004
  • 3) Teasell RW, Mehta S, Aubut J anne L, et al. A systematic review of pharmacologic treatments of pain after spinal cord injury. Arch Phys Med Rehabil. 2010; 91(5): 816-831. doi: 10. 1016/j. apmr. 2010. 01. 022
  • 4) Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: Basic science mechanisms and clinical effectiveness. J Pain. 2003; 4(3): 109-121. doi: 10. 1054/jpai. 2003. 434
  • 5) Tihanyi BT, Ferentzi E, Beissner F, et al. The neuropsychophysiology of tingling. Conscious Cogn. 2018; 58(June): 97-110. doi: 10. 1016/j. concog. 2017. 10. 015
残りの24件を表示する
  • 6) Hershman DL, Lacchetti C, Dworkin RH, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2014; 32(18): 1941-1967. doi: 10. 1200/JCO. 2013. 54. 0914
  • 7) Nishi Y, Ikuno K, Minamikawa Y, et al. A novel form of transcutaneous electrical nerve stimulation for the reduction of dysesthesias caused by spinal nerve dysfunction: A case series. Front Hum Neurosci. 2022; 16. doi: 10. 3389/fnhum. 2022. 937319
  • 8) Pustejovsky JE, Hedges LV, Shadish WR. Design-comparable effect sizes in multiple baseline designs. J Educ Behav Stat. 2014; 39(5): 368-393. doi: 10. 3102/1076998614547577
  • 9) Manolov R, Moeyaert M, Fingerhut JE. A Priori justification for effect measures in single-case experimental designs. Perspect Behav Sci. 2022; 45(1): 153-186. doi: 10. 1007/s40614-021-00282-2
  • 10) Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire(SF-MPQ-2). Pain. 2009; 144(1): 35-42. doi: 10. 1016/j. pain. 2009. 02. 007
  • 11) Gewandter JS, Chaudari J, Ibegbu C, et al. Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study. Support Care Cancer. 2019; 27(5): 1765-1774. doi: 10. 1007/s00520-018-4424-6
  • 12) Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain. 2004; 108(3): 248-257. doi: 10. 1016/j. pain. 2003. 12. 024
  • 13) Heinemann AW, Linacre JM, Wright BD, et al. Relationships between impairment and physical disability as measured by the functional independence measure. Arch Phys Med Rehabil. 1993; 74(6): 566-573. doi: 10. 1016/0003-9993(93)90153-2
  • 14) Fugl-Meyer AR, Jaasko L, Leyman I, et al. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975; 7(1): 13-31. http://www.ncbi.nlm.nih.gov/pubmed/1135616
  • 15) Betz R, Biering-Sorensen F, Burns S, et al. The 2019 revision of the International Standards for Neurological Classification of Spinal Cord Injury(ISNCSCI)-What's new? Spinal Cord. 2019; 57(10): 815-817. doi: 10. 1038/s41393-019-0350-9
  • 16) Hedges LV, Pustejovsky JE, Shadish WR. A standardized mean difference effect size for single case designs. Res Synth Methods. 2012; 3(3): 224-239. doi: 10. 1002/jrsm. 1052
  • 17) Hedges LV, Pustejovsky JE, Shadish WR. A standardized mean difference effect size for multiple baseline designs across individuals. Res Synth Methods. 2013; 4(4): 324-341. doi: 10. 1002/jrsm. 1086
  • 18) Fingerhut J, Xu X, Moeyaert M. Impact of within-case variability on Tau-U indices and the hierarchical linear modeling approach for multiple-baseline design data: A Monte Carlo simulation study. Evid Based Commun Assess Interv. 2021; 15(3): 115-141. doi: 10. 1080/17489539. 2021. 1933727
  • 19) Parker RI, Vannest KJ, Davis JL, et al. Combining nonoverlap and trend for single-case research: Tau-U. Behav Ther. 2011; 42(2): 284-299. doi: 10. 1016/j. beth. 2010. 08. 006
  • 20) Tarlow KR. An improved rank correlation effect size statistic for single-case designs: Baseline corrected Tau. Behav Modif. 2017; 41(4): 427-467. doi: 10. 1177/0145445516676750
  • 21) Vannest KJ, Ninci J. Evaluating intervention effects in single-case research designs. J Couns Dev. 2015; 93(4): 403-411. doi: 10. 1002/jcad. 12038
  • 22) Kuwabara S, Misawa S. Axonal Ionic pathophysiology in human peripheral neuropathy and motor neuron disease. Curr Neurovasc Res. 2004; 1(4): 373-379. doi: 10. 2174/1567202043362162
  • 23) Zhao R, Zhou H, Huang L, et al. Neuropathic pain causes pyramidal neuronal hyperactivity in the anterior cingulate cortex. Front Cell Neurosci. 2018; 12. doi: 10. 3389/fncel. 2018. 00107
  • 24) Mazzola L, Isnard J, Mauguiere F. Somatosensory and pain responses to stimulation of the second somatosensory area(SII)in humans. A Comparison with SI and Insular Responses. Cereb Cortex. 2006; 16(7): 960-968. doi: 10. 1093/cercor/bhj038
  • 25) Melzack R, Wall PD. Pain mechanisms: A new theory. Pain Clin. 1994; 7(1): 57-72. doi: 10. 1017/cbo9780511759048. 009
  • 26) Kasat V, Gupta A, Ladda R, et al. Transcutaneous electric nerve stimulation(TENS) in dentistry-A review. J Clin Exp Dent. 2014; 6(5): e562-e568. doi: 10. 4317/jced. 51586
  • 27) Vance CGT, Dailey DL, Rakel BA, et al. Using TENS for pain control: the state of the evidence. Pain Manag. 2014; 4(3): 197-209. doi: 10. 2217/pmt. 14. 13
  • 28) Meyer-Friessem CH, Wiegand T, Eitner L, et al. Effects of spinal cord and peripheral nerve stimulation reflected in sensory profiles and endogenous pain modulation. Clin J Pain. 2019; 35(2): 111-120. doi: 10. 1097/AJP. 0000000000000661
  • 29) Deer TR, Jain S, Hunter C, et al. Neurostimulation for intractable chronic pain. Brain Sci. 2019; 9(2): 1-20. doi: 10. 3390/brainsci9020023
はじめての方へ
個人／法人会員登録のご案内